How to adjust the usage and dosage of ivonib? How should different patients take it correctly?

Ivosidenib is an oral targeted drug mainly used to treat acute myeloid leukemia (AML) and cholangiocarcinoma carrying IDH1 mutations. The recommended standard dose is usually 500 mg once daily with or without food. Patients should insist on taking the medicine regularly every day according to the doctor's instructions to maintain a stable blood concentration and ensure the therapeutic effect.

Dose adjustments may be necessary in patients who experience adverse reactions . For example, if severe QT interval prolongation, abnormal liver function, or differentiation syndrome occurs, the doctor may recommend temporarily stopping the drug and then reducing the dose to resume treatment after the symptoms are relieved. When adjusting dosage, electrocardiogram and liver function should be monitored regularly to ensure safety.

Different patients may have different medication regimens. For patients with impaired renal or hepatic function , medication should be used with caution, and the dosage or medication interval should be adjusted under the guidance of a doctor. If the patient is taking CYP3A4 strong inhibitors or inducers, the metabolism of ivonib may be affected, and joint use or dose adjustment must be avoided.

Patients should strictly follow the doctor's instructions and should not increase or decrease the dose or stop medication at will. If you forget to take a dose, you should take it as soon as possible, but if it is close to the next dose time, skip the missed dose and avoid doubling the dose. If you experience serious side effects or disease progression, you should seek medical treatment promptly and discuss further treatment options with your doctor.